Literature DB >> 26817464

Reversible MRI Changes in an Infant with Epileptic Spasms on Low Dose Vigabatrin.

Puneet Jain1, Raman Alwadhi2, Vikash Kumar3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26817464     DOI: 10.1007/s12098-015-2020-z

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  4 in total

1.  Abnormal axial diffusivity in the deep gray nuclei and dorsal brain stem in infantile spasm treated with vigabatrin.

Authors:  G N Simao; S Zarei Mahmoodabadi; O C Snead; C Go; E Widjaja
Journal:  AJNR Am J Neuroradiol       Date:  2010-08-26       Impact factor: 3.825

2.  Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy.

Authors:  James W Wheless; Lionel Carmant; Martina Bebin; Joan A Conry; Catherine Chiron; Roy D Elterman; Michael Frost; Juliann M Paolicchi; W Donald Shields; Elizabeth A Thiele; Mary L Zupanc; Stephen D Collins
Journal:  Epilepsia       Date:  2008-11-17       Impact factor: 5.864

3.  Cerebral MRI abnormalities associated with vigabatrin therapy.

Authors:  Phillip L Pearl; Louis G Vezina; Russell P Saneto; Robert McCarter; Elizabeth Molloy-Wells; Ari Heffron; Stacey Trzcinski; William M McClintock; Joan A Conry; Nancy J Elling; Howard P Goodkin; Marcio Sotero de Menezes; Raymond Ferri; Elizabeth Gilles; Nadja Kadom; William D Gaillard
Journal:  Epilepsia       Date:  2008-09-08       Impact factor: 5.864

4.  An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms.

Authors:  Choong Yi Fong; John P Osborne; Stuart W Edwards; Cheryl Hemingway; Eleanor Hancock; Anthony L Johnson; Colin R Kennedy; Rachel Kneen; Marcus Likeman; Andrew L Lux; Santosh R Mordekar; Velayutham Murugan; Richard W Newton; Michael Pike; Michael Quinn; Stefan Spinty; Grace Vassallo; Christopher M Verity; Andrea Whitney; Finbar J K O'Callaghan
Journal:  Dev Med Child Neurol       Date:  2013-06-22       Impact factor: 5.449

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.